Charles Faith L.

Track

Insider profile

Performance

Overall performance
3.2
Performance over holding periods
4.2
30 days 90 days 120 days
Average return 4% 8.2% 15.1%
Success rate 34% 68% 82%
Transactions
4 75% Buy
34 71% Buy
47 69% Buy
Ranking by holding-period performance
Performance for realised trades
4.4
Average return 79%
Success rate 73%
Average holding period 220
Transactions 28
Ranking by realised performance
Charles Faith L.'s trades of CNS Pharmaceuticals Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
60.63
Quantity 264 -20.3%
Value US$2,013,563
Transaction date
Proposed sale
Price
314.72
Quantity 14,885
Value US$224,571
Transaction date
Purchase
Price
3.28
Quantity 7,550 +10.7%
Value US$24,764
Transaction date
Purchase
Price
3.28
Quantity 7,550 +10.7%
Value US$24,764
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2026-05-20 2026-05-18
B Purchase
264 -20.3%
60.63
US$2,013,563 		264 -20.3% 60.63 US$2,013,563
2025-07-10 2025-07-09
S Sale
57,959 +31.1%
340.19
US$2,169,895 		57,959 +31.1% 340.19 US$2,169,895
2025-07-09 2025-07-09
PrS Proposed sale
14,885
314.72
US$224,571 		14,885 314.72 US$224,571
2024-04-29 2024-04-26
B Purchase
7,550 +10.7%
3.28
US$24,764 		7,550 +10.7% 3.28 US$24,764
2024-04-29 2024-04-26
B Purchase
7,550 +10.7%
3.28
US$24,764 		7,550 +10.7% 3.28 US$24,764
2023-09-29 2023-09-27
S Sale
8,330 -10.5%
4.91
US$40,924 		8,330 -10.5% 4.91 US$40,924